Klauda JB, Venable RM, Freites JA, OConnor JW, Tobias DJ, Mondragon-Ramirez C, Vorobyov I, Mackerell AD Jr, Pastor RW (2010) Update of the CHARMM all-atom additive force field for lipids: validation on six lipid types
GLP-1 therapies have been shown to relieve the burden on the ER, reduce ER stress, and decrease subsequent hepatocyte apoptosis (Sharma et al., 2011)
QSRs and food delivery: The uncomfortable question In the US, early data is already showing behavioral changes: Walmart and Target reported declining sales of snack foods in areas with high GLP-1 adoption PepsiCo and Nestl have launched GLP-1-friendly product lines Restaurant traffic among GLP-1 users dropped 20-30% in some studies Now consider Indias food landscape: QSR market size: 50,000+ crore and growing at 18-20% annually Food delivery GMV: 70,000+ crore (Zomato, Swiggy combined) Packaged snacks market: 35,000+ crore If GLP-1 drugs achieve even 5% penetration among Indias urban population (roughly 5-6 million users), the impact on discretionary food spending could be material
Purity: You prevent contamination
2010, 2 (49): 49ps47-10.1126/scitranslmed.3001027
Robert Popovian 00:59 No, but I have to say its sadly it has to do with drug shortages that in the United States, drug shortages increased by nearly 30%, between 2021 and 2022, according to a report commissioned by the Senate earlier this year, and this is an excellent transition to get into our topic for today
